Friday, August 12, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

by Medical Finance
in Coronavirus
Study: SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021. Image Credit: Dotted Yeti / Shutterstock.com
13
SHARES
139
VIEWS
Share on FacebookShare on Twitter

In a recent study published in the United States Centers for Disease Control and Prevention (CDC) Emerging Infectious Diseases journal, researchers investigate the spread and transmission ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages B.1.619 and B.1.620 in South Korea.

Study: SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021. Image Credit: Dotted Yeti / Shutterstock.com

Study: SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021. Image Credit: Dotted Yeti / Shutterstock.com

Background

Over two million genomes of SARS-CoV-2 have been identified since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, thus demonstrating that this virus is highly mutational.

Studies have shown that the SARS-CoV-2 spike protein attaches itself to the host cell angiotensin-converting enzyme 2 (ACE2) receptor during infection. Mutations in the spike protein receptor-binding domain (RBD) have led to the emergence of several SARS-CoV-2 variants of concern (VOC).

SARS-CoV-2 VOCs identified by the World Health Organization (WHO) are known to cause serious health implications. These variants included Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529). Each of these variants exhibits higher transmissibility, evades the immune system, is more likely to cause severe symptoms, reduce the effectiveness of vaccines, and escape detection.

ImageForNews 701090 16417765313614235

Investigation of SARS-CoV-2 B.1.619 and B.1.620 lineages, South Korea, 2021. A) Distribution of 7 SARS-CoV-2 lineages in domestic cases over time. Data are shown for lineages A, B.41, B.1.497, B.1.1.7 (Alpha variant), B.1.617.2 (Delta variant), B.1.619.1, and B.1.620. B) Number of sequenced genomes over time, by lineage. C) Logarithmic graph of cumulative cases of variants indexed by days since the first reported case as of July 21, 2021. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

About the study

In the current study, researchers investigate the constant mutation of SARS-CoV-2 and the emergence of new variants to efficiently monitor the effect of variants on disease severity and other factors affecting public health.

The researchers collected nasopharyngeal and oropharyngeal swab samples from COVID-19-positive patients who were tested using real-time reverse transcription PCR (rRT-PCR). These samples were used to prepare whole-genome sequencing (WGS) libraries and were later sequenced appropriately. The researchers then aligned whole genomic sequences for phylogenetic tree analysis, where the maximum-likelihood phylogenetic trees were inferred and visualized.

The researchers acquired SARS-CoV-2 WGS libraries of more than 5% of the total reported COVID-19-positive cases as of July 21, 2021. They filtered out total positive cases from the period of April to July 2021, which is when the number of individuals infected with SARS-CoV-2 lineages B.1.619 and B.1.620 exhibited a sharp increase.

A and B.41 lineages were most commonly found at the beginning of the pandemic in South Korea, while the B.1.497 lineage became prevalent in March 2020. In June 2021, the prevalence of the Alpha variant increased to 22%, whereas the B.1.619 and B.1.620 variants reached 11.5%, and the B.1.497 lineage decreased from 94.3% to 0.9%.

Study findings

The researchers found that the B.1.619 and B.1.620 lineages show several distinctive spike protein mutations but share the E484K mutation. These specific mutations in the spike protein have been found to significantly influence SARS-CoV-2 pathogenesis.

Other than the E484K mutation, the B.1.619 lineage has N440K mutations, which might make the lineage resistant to monoclonal antibodies and enhance its binding affinity to the ACE2 receptor. The B.1.620 lineage has S447N substitutions, which help evade antibody-mediated immunity while also improving RBD affinity for ACE2.

ImageForNews 701090 16417765867479210

Phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 sequences, South Korea. A total of 457 sequences were used to construct the tree, including 37 sequences of B.1.619 lineage and 36 sequences of B.1.620 lineage from GISAID (https://www.gisaid.org). Each sequence was aligned to the reference sequence (Wuhan-Hu-1, GenBank accession no. NC_045512) using Geneious Prime software (https://www.geneious.com) and then manually trimmed to equal lengths. A maximum-likelihood phylogenetic tree was reconstructed using FastTree version 2.1.9 (http://www.microbesonline.org/fasttree), under the general time-reversible plus gamma nucleotide substitution model; the phylogenetic tree was visualized using iTOL (https://itol.embl.de). Four variants of concern (B.1.1.7, B.1.351, P.1, and B.1.617.2), 2 variants of interest (B.1.429 and B.1.617.1), and B.1.497, which were the major lineages of the GH clade in South Korea, are shown. Red indicates South Korea B.1.619 sequences and blue, B.1.620; pink indicates Europe B.1.619 sequences and light blue, B.1.620. Scale bar indicates substitutions per site.

The authors also noted that the B.1.619 and B.1.620 lineages do not inhibit the neutralizing activity in vaccinated or convalescent individuals. The combined effect of the lineages on factors like viral pathogenicity and transmissibility needs to be determined in further investigations.

Conclusion

The current study findings demonstrate the various mutations and transmissibility of different SARS-CoV-2 variants in South Korea. Importantly, the transmissibility of the B.1.619 and B.1.620 lineages, as well as their effect on disease severity, is not thoroughly investigated in the study.

According to the researchers, the neutralizing capacity of people who had recovered from non-VOC infections and vaccinated individuals is sufficient to combat infection by these lineages.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Antigenic evolution of SARS-CoV-2 in immunocompromised hosts. Image Credit: Lightspring/Shutterstock

Better global health equality could prevent emergence of future SARS-CoV-2 variants of concern

by Medical Finance
August 12, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers used a simple phenomenological model to investigate the role...

Study: A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients. Image Credit: Alexandros Michailidis/Shutterstock

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

by Medical Finance
August 12, 2022
0

In a recent cross-sectional study posted to the medRxiv* preprint server, researchers used per protocol bronchoalveolar lavage fluid (BALF) samples...

Study: Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes. Image Credit: Iurii Kachkovskyi/Shutterstock

Researchers construct models to predict SARS-CoV-2 mutable and constrained positions

by Medical Finance
August 12, 2022
0

Many variants of concern (VOCs) display mutations in significant positions in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Study: The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness. Image Credit: CROCOTHERY/Shutterstock

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

by Medical Finance
August 12, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped coronavirus with a single-stranded RNA genome. The SARS-CoV-2 exhibits...

Study: researchers reviewed the material properties and administration routes that could successfully deliver a messenger ribonucleic acid (mRNA) therapeutic agent to its targeted site. Image Credit: thodonal88/Shutterstock

Exploring strategies for successful delivery of messenger RNA therapeutics

by Medical Finance
August 12, 2022
0

In a recent study published in the journal Materials Today Advances, researchers reviewed the material properties and administration routes that...

Study: COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains. Image Credit: Bignai/Shutterstock

Study reveals aerosol transmission of SARS-CoV-2 via floor drains

by Medical Finance
August 12, 2022
0

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has threatened public health...

Next Post
KHN’s ‘What the Health?’: FDA takes center stage

Study shows how microglia contribute to slowdown of neuron activity linked with Alzheimer’s

New low-calorie sweetener could potentially have a prebiotic effect on the gut microbiome

New low-calorie sweetener could potentially have a prebiotic effect on the gut microbiome

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers. Image Credit: Juan Gaertner/Shutterstock
    Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays
  • Study: Genetic risk and incident venous thromboembolism in middle-aged and older adults following Covid-19 vaccination. Image Credit: Vitalii Vodolazskyi/Shutterstock
    Incidence of venous thromboembolism following COVID-19 vaccination
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply